JP2008500376A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008500376A5 JP2008500376A5 JP2007517026A JP2007517026A JP2008500376A5 JP 2008500376 A5 JP2008500376 A5 JP 2008500376A5 JP 2007517026 A JP2007517026 A JP 2007517026A JP 2007517026 A JP2007517026 A JP 2007517026A JP 2008500376 A5 JP2008500376 A5 JP 2008500376A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- use according
- cryptoxanthin
- muscle cells
- animal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 claims 12
- DMASLKHVQRHNES-UPOGUZCLSA-N (3R)-beta,beta-caroten-3-ol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C DMASLKHVQRHNES-UPOGUZCLSA-N 0.000 claims 8
- NBZANZVJRKXVBH-ITUXNECMSA-N all-trans-alpha-cryptoxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CCCC2(C)C)C NBZANZVJRKXVBH-ITUXNECMSA-N 0.000 claims 8
- DMASLKHVQRHNES-ITUXNECMSA-N beta-cryptoxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CCCC2(C)C DMASLKHVQRHNES-ITUXNECMSA-N 0.000 claims 8
- 235000002360 beta-cryptoxanthin Nutrition 0.000 claims 8
- 239000011774 beta-cryptoxanthin Substances 0.000 claims 8
- 238000000034 method Methods 0.000 claims 7
- 241001465754 Metazoa Species 0.000 claims 6
- 210000000663 muscle cell Anatomy 0.000 claims 5
- 230000014616 translation Effects 0.000 claims 5
- 102000004169 proteins and genes Human genes 0.000 claims 4
- 108090000623 proteins and genes Proteins 0.000 claims 4
- 230000001737 promoting effect Effects 0.000 claims 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims 2
- 241000282412 Homo Species 0.000 claims 2
- 230000009758 senescence Effects 0.000 claims 2
- 206010006895 Cachexia Diseases 0.000 claims 1
- 208000017667 Chronic Disease Diseases 0.000 claims 1
- 239000004212 Cryptoxanthin Substances 0.000 claims 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims 1
- 208000030814 Eating disease Diseases 0.000 claims 1
- 208000019454 Feeding and Eating disease Diseases 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 claims 1
- 206010061363 Skeletal injury Diseases 0.000 claims 1
- 208000036142 Viral infection Diseases 0.000 claims 1
- 229930003268 Vitamin C Natural products 0.000 claims 1
- 229930003427 Vitamin E Natural products 0.000 claims 1
- 239000003833 bile salt Substances 0.000 claims 1
- 230000018109 developmental process Effects 0.000 claims 1
- 235000014632 disordered eating Nutrition 0.000 claims 1
- 230000000694 effects Effects 0.000 claims 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims 1
- 241000411851 herbal medicine Species 0.000 claims 1
- 239000007788 liquid Substances 0.000 claims 1
- 244000144972 livestock Species 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 208000010125 myocardial infarction Diseases 0.000 claims 1
- 210000000056 organ Anatomy 0.000 claims 1
- 208000001076 sarcopenia Diseases 0.000 claims 1
- 239000008247 solid mixture Substances 0.000 claims 1
- 238000001356 surgical procedure Methods 0.000 claims 1
- 238000002560 therapeutic procedure Methods 0.000 claims 1
- 230000009385 viral infection Effects 0.000 claims 1
- 235000019154 vitamin C Nutrition 0.000 claims 1
- 239000011718 vitamin C Substances 0.000 claims 1
- 235000019165 vitamin E Nutrition 0.000 claims 1
- 229940046009 vitamin E Drugs 0.000 claims 1
- 239000011709 vitamin E Substances 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04.011743.4 | 2004-05-18 | ||
| EP04011743 | 2004-05-18 | ||
| PCT/EP2005/005030 WO2005110122A1 (en) | 2004-05-18 | 2005-05-10 | USE OF β-CRYPTOXANTHIN |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012203513A Division JP2013047227A (ja) | 2004-05-18 | 2012-09-14 | β−クリプトキサンチンの使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2008500376A JP2008500376A (ja) | 2008-01-10 |
| JP2008500376A5 true JP2008500376A5 (enExample) | 2011-11-17 |
| JP5145035B2 JP5145035B2 (ja) | 2013-02-13 |
Family
ID=34966671
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007517026A Expired - Fee Related JP5145035B2 (ja) | 2004-05-18 | 2005-05-10 | β−クリプトキサンチンの使用 |
| JP2012203513A Pending JP2013047227A (ja) | 2004-05-18 | 2012-09-14 | β−クリプトキサンチンの使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012203513A Pending JP2013047227A (ja) | 2004-05-18 | 2012-09-14 | β−クリプトキサンチンの使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20080070980A1 (enExample) |
| EP (1) | EP1748705B1 (enExample) |
| JP (2) | JP5145035B2 (enExample) |
| KR (1) | KR101317976B1 (enExample) |
| CN (1) | CN1953669B (enExample) |
| AT (1) | ATE484201T1 (enExample) |
| DE (1) | DE602005024128D1 (enExample) |
| ES (1) | ES2351701T3 (enExample) |
| WO (1) | WO2005110122A1 (enExample) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPWO2008013219A1 (ja) * | 2006-07-28 | 2009-12-17 | ユニチカ株式会社 | クリプトキサンチンの高吸収性経口投与組成物 |
| US20090118227A1 (en) | 2007-11-07 | 2009-05-07 | Bristol-Myers Squibb Company | Carotenoid-containing compositions and methods |
| JP5688697B2 (ja) * | 2009-09-25 | 2015-03-25 | 国立大学法人愛媛大学 | 免疫蛋白質の産生促進剤 |
| JP5909084B2 (ja) * | 2010-12-15 | 2016-04-26 | アークレイ株式会社 | 安定化βクリプトキサンチン含有水およびその用途 |
| CN102219721B (zh) * | 2011-04-02 | 2013-08-07 | 秦皇岛大惠生物技术有限公司 | 一种含有β-隐黄质的浓缩物的提取方法与采用该方法所得到的浓缩物及其用途 |
| WO2013009378A1 (en) * | 2011-07-13 | 2013-01-17 | University Of Georgia Research Foundation, Inc. | Use of xanthophyll carotenoids to improve visual performance and neural efficiency |
| BR112015007131A2 (pt) * | 2012-10-04 | 2017-07-04 | Abbott Lab | métodos para melhorar o efeito de egcg em atenuar a perda muscular esquelética |
| JP5687682B2 (ja) * | 2012-12-20 | 2015-03-18 | ユニチカ株式会社 | カルシウム吸収促進組成物 |
| SG11201505759RA (en) | 2013-01-24 | 2015-08-28 | Omniactive Health Technologies Ltd | Beta-cryptoxanthin from plant source and a process for its preparation |
| KR20160016926A (ko) * | 2013-05-31 | 2016-02-15 | 디에스엠 아이피 어셋츠 비.브이. | 사료 보충제 및 이의 용도 |
| CN107205439A (zh) * | 2015-01-15 | 2017-09-26 | 帝斯曼知识产权资产管理有限公司 | 具有25‑羟基维生素d和抗氧化剂/抗炎剂的组合的家禽饲料 |
| US10568846B2 (en) * | 2015-04-27 | 2020-02-25 | Omniactive Health Technologies Limited | Betacryptoxanthin compositions, processes for preparation and uses thereof |
| CN104906112B (zh) * | 2015-05-20 | 2018-02-23 | 杨克西 | 一种促进蛋白质合成的组合物及其制备方法和用途 |
| JP2019218316A (ja) * | 2018-06-21 | 2019-12-26 | 公立大学法人大阪 | オートファジー活性向上剤 |
| SG10201900604TA (en) | 2019-01-23 | 2020-08-28 | Agency For Science Technology And Research Astarstar | Pre-natal beta-cryptoxanthin benefits children |
| WO2022018162A1 (en) | 2020-07-22 | 2022-01-27 | Dsm Ip Assets B.V. | FORMULATIONS OF NEW β-CRYPTOXANTHIN CRYSTAL FORM, PROCESSES FOR THEIR MANUFACTURE AND THEIR USES |
| WO2022018161A1 (en) | 2020-07-22 | 2022-01-27 | Dsm Ip Assets B.V. | Beta-cryptoxanthin crystal forms, liquid formulations thereof and processes for their manufacture |
| CN115530381A (zh) * | 2022-08-17 | 2022-12-30 | 中南大学 | 预防产前抑郁症的蛋白粉及其制备方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6582721B1 (en) * | 1999-09-17 | 2003-06-24 | Alcon, Inc. | Stable carotene-xanthophyll beadlet compositions and methods of use |
| US6902739B2 (en) * | 2001-07-23 | 2005-06-07 | Nutracea | Methods for treating joint inflammation, pain, and loss of mobility |
| US8148431B2 (en) * | 2002-10-25 | 2012-04-03 | Kemin Health, L.C. | Osteogenesis promoter containing β-cryptoxanthin as the active ingredient |
-
2005
- 2005-05-10 KR KR1020067024056A patent/KR101317976B1/ko not_active Expired - Fee Related
- 2005-05-10 EP EP05738192A patent/EP1748705B1/en not_active Expired - Lifetime
- 2005-05-10 AT AT05738192T patent/ATE484201T1/de not_active IP Right Cessation
- 2005-05-10 US US11/596,618 patent/US20080070980A1/en not_active Abandoned
- 2005-05-10 DE DE602005024128T patent/DE602005024128D1/de not_active Expired - Lifetime
- 2005-05-10 WO PCT/EP2005/005030 patent/WO2005110122A1/en not_active Ceased
- 2005-05-10 CN CN2005800158315A patent/CN1953669B/zh not_active Expired - Fee Related
- 2005-05-10 ES ES05738192T patent/ES2351701T3/es not_active Expired - Lifetime
- 2005-05-10 JP JP2007517026A patent/JP5145035B2/ja not_active Expired - Fee Related
-
2012
- 2012-09-14 JP JP2012203513A patent/JP2013047227A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008500376A5 (enExample) | ||
| US9937198B2 (en) | Multi-functional composition and preparation method and application thereof | |
| TWI407963B (zh) | Contains the composition of riboflavin and sesamin | |
| JP2012023985A (ja) | 飼育動物用動脈硬化抑制飼料 | |
| Klein | Preventive and therapeutic efficacy of halofuginone-lactate against Cryptosporidium parvum in spontaneously infected calves: a centralised, randomised, double-blind, placebo-controlled study | |
| JP2011157302A (ja) | 深部体温正常化剤および体温正常化組成物 | |
| WO2006013427A3 (en) | Treatment of ccr2 mediated diseases or disorders | |
| KR102645209B1 (ko) | 항스트레스, 항불안, 및 항우울 활성을 갖는 작용제 및 이를 기반으로 하는 조성물 | |
| JP2006197911A (ja) | 蜂の子利用の健康食品。 | |
| JP2005521426A5 (enExample) | ||
| Firyal et al. | Elephant as a veterinary patient | |
| RU2004109902A (ru) | Лечебный корм для рыб | |
| Huntington et al. | Nutrition and the equine foot | |
| US20090176871A1 (en) | Treatments for Domestic Animals Having Sex Hormone Deficiencies Using Soy Germ Isoflavones | |
| Kumar et al. | Indigenous livestock practices of tribal farmers | |
| RU2786095C1 (ru) | Противопаразитная композиция для маралов-рогачей и способ ее применения | |
| Panigrahi | Conservative treatment of hip dysplasia in a Labrador dog-A case study | |
| JP2005200390A (ja) | 持久力増強剤および抗疲労剤 | |
| CN100490651C (zh) | 鼠类动物专用服食剂及制备方法 | |
| Floyd et al. | General Supportive Care for the Laminitis Case | |
| KR101303925B1 (ko) | 숯을 이용한 가축의 설사 예방 및 치료용 조성물 | |
| CN106860630A (zh) | 一种防治鱼类链球菌病的组合物 | |
| Doyle et al. | Donkeys | |
| RU2006112147A (ru) | Способ комплексной активизации деятельности защитных приспособлений организма животного | |
| RU2000125984A (ru) | Способ лечения и профилактики железодефицитной анемии у сельскохозяйственных животных |